Merck Zostavax, Rotateq To Receive Committee Reviews In December
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Vaccines & Related Biological Products Advisory Committee will meet Dec. 14-15 to discuss the herpes zoster and rotavirus vaccines.